Birdwatch Archive

Birdwatch Note Rating

2023-08-26 04:47:21 UTC - HELPFUL

Rated by Participant: 4F9B4FD02E55E4DF22950F5F561C852C30206C0D4E941BB17A20D2A2FD79F4DD
Participant Details

Original Note:

EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/

All Note Details

Original Tweet

All Information

  • noteId - 1695190002055970932
  • participantId -
  • raterParticipantId - 4F9B4FD02E55E4DF22950F5F561C852C30206C0D4E941BB17A20D2A2FD79F4DD
  • createdAtMillis - 1693025241511
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 16951900020559709324F9B4FD02E55E4DF22950F5F561C852C30206C0D4E941BB17A20D2A2FD79F4DD